Glycosidase Inhibitors - All Glycosidase Inhibitors
IN200000

(3aR,6S,7R,7aS)-2-(Ethylamino)-5,6,7,7a-tetrahydro-5-(hydroxymethyl)pyrano[3,2-d]thiazole-6,7-diol

Description: Thiamet-G is a highly selective inhibitor of O-GlcNAc-specific hexosaminidase (O-GlcNAcase) in humans. Thiamet-G may find wide use in probing the functional role of O-GlcNAc in vertebrate brain, and it may also offer a route to blocking pathological

Mol. Formula: C9H16N2O4S

CAS. No.: 1009816-48-1

(3aR,6S,7R,7aS)-2-(Dimethylamino)-5,6,7,7a-tetrahydro-5-(hydroxymethyl)pyrano[3,2-d]thiazole-6,7-diol

Description: Thiamet-G is a highly selective inhibitor of O-GlcNAc-specific hexosaminidase (O-GlcNAcase) in humans. Thiamet-G may find wide use in probing the functional role of O-GlcNAc in vertebrate brain, and it may also offer a route to blocking pathological

Mol. Formula: C9H16N2O4S

(3aR,6S,7R,7aS)-2-(Ethylamino)-5,6,7,7a-tetrahydro-5-(acetoxymethyl)pyrano[3,2-d]thiazole-6,7-diacetate

Description: Thiamet-G is a highly selective inhibitor of O-GlcNAc-specific hexosaminidase (O-GlcNAcase) in humans. Thiamet-G may find wide use in probing the functional role of O-GlcNAc in vertebrate brain, and it may also offer a route to blocking pathological

Mol. Formula: C15H22N2O7S

4-F-GlcNAc

Description: Fluorinated glucosamine has been shown to block the synthesis of key carbohydrate structures linked to cancer progression via interference with UDP-GlcNAc synthesis.

Mol. Formula: C8H14FNO5

4-F-GlcNAc(Ac)3

Mol. Formula: C14H20FNO8